IP Library › Granted Patent US 7,201,925
Granted Patent B2
US 7,201,925 · App. 10/770,132 · Granted Apr 10, 2007

Treatment of ungual and subungual diseases

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,201,925
App. No.
10/770,132
Granted
Apr 10, 2007
Kind
B2
Abstract

The treatment of ungual and subungual diseases is disclosed.

Claims (22)

1. A method for the treatment of an ungual or subungual disease of a subject, the method comprising:

administering via a needleless injector an effective ungual or subungual disease treating amount of a metal-containing material to an area of the subject associated with said disease, wherein the metal-containing material is an atomically disordered, nanocrystalline material that contains a metal selected from the group consisting of silver, gold, platinum and palladium.

2. The method of claim 1 , wherein the disease is selected from the group consisting of onychomycosis, tinea unguim infection, and combinations thereof.

3. The method of claim 1 , wherein the disease is selected from the group consisting of onychomycosis, tinea unguim infection, psoriasis of the unguis, eczema of the unguis, lichen planus of the unguis, viral warts of the unguis and combinations thereof.

4. The method of claim 1 , wherein the disease is a subungual disease.

5. The method of claim 1 , wherein the disease is an ungual disease.

6. The method of claim 1 , wherein the area of the subject comprises an unguis.

7. The method of claim 6 , wherein the subject is a human and the unguis is a toe nail.

8. The method of claim 6 , wherein the subject is a human and the unguis is a finger nail.

9. The method of claim 1 , wherein the area of the subject comprises tissue adjacent to an unguis of the subject.

10. The method of claim 9 , wherein the tissue adjacent to the unguis of the subject comprises skin.

11. The method of claim 1 , wherein the needleless injector delivers the metal containing-material into an unguis of the subject.

12. The method of claim 1 , wherein the needleless injector delivers the metal containing-material through the unguis of the subject.

13. The method of claim 1 , wherein the needleless injector delivers the metal containing-material into tissue adjacent to an unguis of the subject.

14. The method of claim 13 , wherein the tissue adjacent to the unguis of the subject comprises skin.

15. The method of claim 13 , wherein the needleless injector delivers the metal containing-material through the tissue adjacent to the unguis.

16. The method of claim 15 , wherein the tissue adjacent to the unguis of the subject comprises skin.

17. The method of claim 1 , wherein the needleless injector delivers the metal containing-material into an unguis of the subject and into tissue adjacent to the unguis of the subject.

18. The method of claim 17 , wherein the needleless injector delivers the metal containing-material through the unguis of the subject.

19. The method of claim 18 , wherein the needleless injector delivers the metal containing-material through tissue adjacent to an unguis of the subject.

20. The method of claim 17 , wherein the needleless injector delivers the metal containing-material through tissue adjacent to an unguis of the subject.

21. The method of claim 1 , wherein the subject is a human.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 17, 2004
From: GILLIS, SCOTT H.
To: NUCRYST PHARMACEUTICALS CORP.
Reel/Frame 014640/0133 →